AAPG

SEC source: 0001213900-26-060632 · marketforms-73254.xml · derivative · entry 12

Zhai Yifan · CIK 0002123017 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 0

Underlying: Ordinary Shares · 95,575 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · security: Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026.

F10 · derivative.exercise_date: Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026.

F10 · derivative.expiration_date: Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026.

SEC source: 0001213900-26-060632 · marketforms-73254.xml · derivative · entry 10

Zhai Yifan · CIK 0002123017 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 92,746 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · security: Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026.

F9 · derivative.exercise_date: Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026.

F9 · derivative.expiration_date: Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026.

SEC source: 0001213900-26-060632 · marketforms-73254.xml · nonDerivative · entry 3

Zhai Yifan · CIK 0002123017 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote (2)

Disclosed balance after: 1,193,569

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · ownership.nature: Shares held by Reporting Person's spouse. The Reporting Person disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

SEC source: 0001213900-26-060632 · marketforms-73254.xml · nonDerivative · entry 1

Zhai Yifan · CIK 0002123017 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 405,280

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-26-060585 · marketforms-73253.xml · derivative · entry 14

Yang Dajun · CIK 0002059751 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 0

Underlying: Ordinary Shares · 92,746 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · security: Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026.

F11 · derivative.exercise_date: Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026.

F11 · derivative.expiration_date: Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026.

SEC source: 0001213900-26-060585 · marketforms-73253.xml · derivative · entry 6

Yang Dajun · CIK 0002059751 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 95,575 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026.

F5 · shares: Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026.

F5 · derivative.exercise_date: Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026.

F5 · derivative.expiration_date: Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026.

SEC source: 0001213900-26-060585 · marketforms-73253.xml · nonDerivative · entry 2

Yang Dajun · CIK 0002059751 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote (2)

Disclosed balance after: 405,280

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · ownership.nature: Shares held by Reporting Person's spouse. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

SEC source: 0001213900-26-060585 · marketforms-73253.xml · nonDerivative · entry 1

Yang Dajun · CIK 0002059751 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,193,569

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001213900-26-060632 · marketforms-73254.xml · derivative · entry 14

Zhai Yifan · CIK 0002123017 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 298,194

Underlying: Ordinary Shares · 298,194 shares

Expires not disclosed

F6 · security: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant.

F6 · derivative.exercise_date: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant.

F6 · derivative.expiration_date: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant.

SEC source: 0001213900-26-060632 · marketforms-73254.xml · derivative · entry 13

Zhai Yifan · CIK 0002123017 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 298,195

Underlying: Ordinary Shares · 298,195 shares

Expires not disclosed

F5 · security: The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date.

F5 · derivative.exercise_date: The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date.

F5 · derivative.expiration_date: The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date.

SEC source: 0001213900-26-060632 · marketforms-73254.xml · derivative · entry 11

Zhai Yifan · CIK 0002123017 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 95,575

Underlying: Ordinary Shares · 95,575 shares

Expires not disclosed

F8 · security: The RSUs vested on 05/21/2026 and had no expiration date.

F8 · derivative.expiration_date: The RSUs vested on 05/21/2026 and had no expiration date.

SEC source: 0001213900-26-060632 · marketforms-73254.xml · derivative · entry 9

Zhai Yifan · CIK 0002123017 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,746

Underlying: Ordinary Shares · 92,746 shares

Expires not disclosed

F8 · security: The RSUs vested on 05/21/2026 and had no expiration date.

F8 · derivative.expiration_date: The RSUs vested on 05/21/2026 and had no expiration date.

SEC source: 0001213900-26-060632 · marketforms-73254.xml · derivative · entry 8

Zhai Yifan · CIK 0002123017 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,364

Underlying: Ordinary Shares · 103,364 shares

Expires not disclosed

F7 · security: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and expire ten years from the date of grant.

F7 · derivative.exercise_date: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and expire ten years from the date of grant.

F7 · derivative.expiration_date: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and expire ten years from the date of grant.

SEC source: 0001213900-26-060632 · marketforms-73254.xml · derivative · entry 7

Zhai Yifan · CIK 0002123017 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 214,988

Underlying: Ordinary Shares · 214,988 shares

Expires not disclosed

F6 · security: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant.

F6 · derivative.exercise_date: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant.

F6 · derivative.expiration_date: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant.

SEC source: 0001213900-26-060632 · marketforms-73254.xml · derivative · entry 6

Zhai Yifan · CIK 0002123017 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 214,999

Underlying: Ordinary Shares · 214,999 shares

Expires not disclosed

F5 · security: The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date.

F5 · derivative.exercise_date: The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date.

F5 · derivative.expiration_date: The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date.

SEC source: 0001213900-26-060632 · marketforms-73254.xml · derivative · entry 5

Zhai Yifan · CIK 0002123017 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,365

Underlying: Ordinary Shares · 103,365 shares

Expires not disclosed

F4 · security: Each restricted stock unit (the "RSUs") represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and have no expiration date.

F4 · derivative.exercise_date: Each restricted stock unit (the "RSUs") represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and have no expiration date.

F4 · derivative.expiration_date: Each restricted stock unit (the "RSUs") represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and have no expiration date.

SEC source: 0001213900-26-060585 · marketforms-73253.xml · derivative · entry 13

Yang Dajun · CIK 0002059751 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 92,746

Underlying: Ordinary Shares · 92,746 shares

Expires not disclosed

F10 · security: The RSUs vested on 05/21/2026 and had no expiration date.

F10 · derivative.expiration_date: The RSUs vested on 05/21/2026 and had no expiration date.

SEC source: 0001213900-26-060585 · marketforms-73253.xml · derivative · entry 12

Yang Dajun · CIK 0002059751 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 103,364

Underlying: Ordinary Shares · 103,364 shares

Expires not disclosed

F9 · security: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and expire ten years from the date of grant.

F9 · derivative.exercise_date: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and expire ten years from the date of grant.

F9 · derivative.expiration_date: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and expire ten years from the date of grant.

SEC source: 0001213900-26-060585 · marketforms-73253.xml · derivative · entry 11

Yang Dajun · CIK 0002059751 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 214,988

Underlying: Ordinary Shares · 214,988 shares

Expires not disclosed

F7 · security: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant.

F7 · derivative.exercise_date: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant.

F7 · derivative.expiration_date: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant.

SEC source: 0001213900-26-060585 · marketforms-73253.xml · derivative · entry 10

Yang Dajun · CIK 0002059751 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 214,999

Underlying: Ordinary Shares · 214,999 shares

Expires not disclosed

F6 · security: The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date.

F6 · derivative.exercise_date: The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date.

F6 · derivative.expiration_date: The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date.

SEC source: 0001213900-26-060585 · marketforms-73253.xml · derivative · entry 9

Yang Dajun · CIK 0002059751 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 103,365

Underlying: Ordinary Shares · 103,365 shares

Expires not disclosed

F8 · security: The RSUs vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and have no expiration date.

F8 · derivative.exercise_date: The RSUs vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and have no expiration date.

F8 · derivative.expiration_date: The RSUs vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and have no expiration date.

SEC source: 0001213900-26-060585 · marketforms-73253.xml · derivative · entry 8

Yang Dajun · CIK 0002059751 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 298,194

Underlying: Ordinary Shares · 298,194 shares

Expires not disclosed

F7 · security: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant.

F7 · derivative.exercise_date: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant.

F7 · derivative.expiration_date: The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant.

SEC source: 0001213900-26-060585 · marketforms-73253.xml · derivative · entry 7

Yang Dajun · CIK 0002059751 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 298,195 shares

Expires not disclosed

F6 · security: The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date.

F6 · derivative.exercise_date: The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date.

F6 · derivative.expiration_date: The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date.

SEC source: 0001213900-26-060585 · marketforms-73253.xml · derivative · entry 5

Yang Dajun · CIK 0002059751 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,575

Underlying: Ordinary Shares · 95,575 shares

Expires not disclosed

F4 · security: Each restricted stock unit (the "RSUs") represent a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vested on 05/21/2026 and had no expiration date.

F4 · derivative.expiration_date: Each restricted stock unit (the "RSUs") represent a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vested on 05/21/2026 and had no expiration date.

F4 · balance_after: Each restricted stock unit (the "RSUs") represent a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vested on 05/21/2026 and had no expiration date.

SEC source: 0001213900-26-046036 · marketforms-72968.xml · derivative · entry 1

Misra Veet · CIK 0002122967 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,584

Underlying: Restricted stock units · 18,584 shares

Expires not disclosed

F1 · derivative.exercise_date: Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest immediately and have no expiration date.

F1 · derivative.expiration_date: Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest immediately and have no expiration date.